Acute hepatopathy associated with mitotane administration in a dog

Journal of the American Animal Hospital Association

Volumn 42, Issue 4, 2006, Pages 298-301

  Webb, Craig B ^a   Twedt, David C ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; BILIRUBIN; FAMOTIDINE; GLUCOSE; LIVER ENZYME; METOCLOPRAMIDE; MITOTANE; NITROGEN; POTASSIUM CHLORIDE; PREDNISONE; S ADENOSYLMETHIONINE; UREA; URSODEOXYCHOLIC ACID; VITAMIN K GROUP;

ANIMAL TISSUE; ANOREXIA; ARTICLE; CELL LOSS; CLINICAL PROTOCOL; DOG DISEASE; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HYPERADRENOCORTICISM; JAUNDICE; LIVER BIOPSY; LIVER CELL; LIVER DISEASE; LIVER FAILURE; NONHUMAN; PROTHROMBIN TIME; UREA NITROGEN BLOOD LEVEL;

CANIS FAMILIARIS;

EID: 33746138063     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0420298     Document Type: Article

References (25)

1. Feldman EC, Nelson RW. Canine hyperadrenocorticism (Cushing's syndrome). In: Feldman EC, Nelson RW, eds. Canine and Feline Endocrinology and Reproduction. 3rd ed. St. Louis: WB Saunders, 2004:252-357.
2. Ling GV, Stabenfeldt GH, Comer KM, et al. Canine hyperadrenocorticism: pretreatment clinical and laboratory evaluation of 117 cases. J Am Vet Med Assoc 1979;174:1211-1215.
3. Behrend EN, Kemppainen RJ. Diagnosis of canine hyperadrenocorticism. Vet Clin North Am Small Anim Pract 2001;31:985-1001.
4. Feldman EC, Nelson RW, Feldman MS. Use of low- and high-dose dexamethasone tests for distinguishing pituitary dependent from adrenal tumor hyperadrenocorticism. J Am Vet Med Assoc 1996;209:772-775.
5. Braddock JA. Medical treatment of hyperadrenocorticism in the dog. Aust Vet J 2003;81:31-33.
6. Feldman EC, Nelson RW, Feldman MS, et al. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs. J Am Vet Med Assoc 1992;200:1642-1647.
7. Peterson ME. Medical treatment of canine pituitary-dependent hyperadrenocorticism (Cushing's disease). Vet Clin North Am Small Anim Pract 2001;31:1005-1014.
8. Hughes D, King LG. The diagnosis and management of acute liver failure in dogs and cats. Vet Clin North Am Small Anim Pract 1995;25:437-460.
9. Center SA. Acute hepatic injury: hepatic necrosis and fulminant hepatic failure. In: Guilford GW, Center SA, Strombeck DR, et al., eds. Small Animal Gastroenterology. Philadelphia: WB Saunders, 1996:654-704.
10. Dial SM. Clinicopathologic evaluation of the liver. Vet Clin North Am Small Anim Pract 1995;25:257-273.
11. Center SA, Slater MR, Manwarren T, et al. Diagnostic efficacy of scrum alkaline phosphatase and Υ-glutamyltransferase in dogs with histologically confirmed hepatobiliary disease: 270 cases (1980-1990). J Am Vet Med Assoc 1992;201:1258-1264.
12. Reusch CE, Feldman EC. Canine hyperadrenocorticism due to adrenocortical neoplasia. J Vet Intern Med 1991;5:3-10.
13. Kipperman. BS, Feldman EC, Dybdal NO, et al. Pituitary tumor size, neurologic signs, and relation to endocrine test results in dogs with pituitary-dependent hyperadrenocorticism: 43 cases (1980-1990). J Am Vat Med Assoc 1992;201:762-767.
14. Peterson ME, Gilbertson SP, Drucker WD. Plasma cortisol response to exogenous ACTH in 22 dogs with hyperadrenocorticism caused by adrenocortical neoplasia. J Am Vet Med Assoc 1982; 180:542-544.
15. Feldman EC. Effect of functional adrenocortical tumors on plasma cortisol and corticotrophin concentrations in dogs. J Am Vet Med Assoc 1981;178:823-826.
16. Kaplan AJ, Peterson ME, Kemppainen RJ. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs. J Am Vet Med Assoc 1995;207:445-451.
17. Zerbe CA, Nachreiner RF, Refsal KF, et al. Adrenal fianction testing in dogs with hyperadrenocorticism [abstract]. Proceed Am Coll Vet Intern Med Forum, San Diego, 1987;Proc 5th ACVIM Forum:883.
18. van Liew CH, Greco DS, Salman MD. Comparison of results of adrenocorticotropic hormone stimulation and low dose dexamethasone suppression tests with necropsy finding in dogs: 81 cases (1985-1995). J Am Vet Med Assoc 1997;211:322-325.
19. Peterson ME. o,p'-DDD (mitotane) treatment of pituitary-dependent canine hyperadrenocorticism. J Am Vet Med Assoc 1983; 182:527-528.
20. Kintzer PP, Peterson ME. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms. J Am Vet Med Assoc 1994;205:54-61.
21. Kintzer PP, Peterson ME. Mitotane (o,p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1991;5:182-190.
22. Boothe DM. Small Animal Clinical Pharmacology and Therapeutics. lst ed. Philadelphia: WB Saunders, 2001:646.
23. Plumb DC. Veterinary Drug Handbook. 4th ed. White Bear Lake, MN: PharmaVet Publishing, 2002.
24. den Hertog E, Braakman JCA, Teske E, et al. Results of non-selective adrenocorticolysis by o,p'-DDD in 129 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 1999; 144:12-17.
25. MacPhail CM, Lappin MR, Meyer DJ, et al. Hepatocellular toxicosis associated with administration of carprofen in 21 dogs. J Am Vet Med Assoc 1998;212:1895-1901.